Latest News - Biotech - Ukraine

The libraries have been designed with QSAR and contain only drug-like compounds. These libraries are proposed for drug development.

Otava has various inhibitors, agonists and other biologically active compounds. Our company offers additional 30% discount on orders of our best selling products. A full list of available compounds on www.otavachemicals.com

Otava releases two GPCR-related focused libraries. The libraries have been designed with QSAR using training set. These libraries are proposed for screening in GPCR-associated research and drug development.

Otava pleased to offer two novel fluorescent dyes. This dyes developed using our innovative "lead dye" method.

Otava presents the new p38 MAP Kinase Alpha focused library. This p38 MAP Kinase Alpha focused library is an excellent and essential starting point in a drug discovery program.

Otava presents the new CDK2 focused library. This CDK2 focused library is an excellent and essential starting point in a drug discovery program.

Otava presents the new proto-oncogene tyrosine-protein kinase ABL1 focused library. This ABL1 focused library is an excellent and essential starting point in a drug discovery program.

New technology for virtual screening improving

ZORG UKRAINE and ILCI (Ankara, Turkey) launched a construction project of a biogas plant, designed to process wastes of a dairy farm, owned by ILCI. Two companies signed a contract on 26.05.06.

“ZORG UKRAINE” has started an exclusive engineering project of a biogas plant for a local Ukrainian company “Zeleny Gai,” allocated in Mykolaivsky region. General intention is for the plant to use corn and perennial native-grasses silo.